Delivery Order SPE2DR25D1104-SPE2DR26FL220

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 6, 2026, for Actemra 162 mg/0.9 mL syringes with a ceiling value of $2,252.22.</p> <p>Place of performance is Conshohocken, PA. The ultimate completion date is February 9, 2026. The order is priced on a firm fixed-price basis and carries no set-aside.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for $32,489.23 (firm fixed price) for Actemra Actpen 162 mg/0.9 ml pharmaceutical product.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is February 11, 2026. The order carries a ceiling value of $32,489.23 and was issued under no set-aside.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for $3,067.68 (firm fixed price) for Actemra Actpen 162 mg/0.9 ml pharmaceutical product.</p> <p>Place of performance is Conshohocken, PA. The order ceiling value is $3,067.68, with an ultimate completion date of February 11, 2026. The delivery order was issued under no set-aside.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 6, 2026, for Actemra Actpen 162 mg/0.9 ml auto-injector pharmaceutical product, with a ceiling value of $15,620.70.</p> <p>Place of performance is Conshohocken, PA. The order has a firm fixed-price structure and an ultimate completion date of February 9, 2026. No set-aside was used.</p>

The Defense Logistics Agency issued a $26,436.07 delivery order to Amerisourcebergen Drug Corp on February 12, 2026, for Actemra Actpen 162 mg/0.9 ml pharmaceutical product. Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 13, 2026, and is priced on a firm fixed-price basis. No set-aside was used. The awardee is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs through the Defense Logistics...

The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for Actemra 162 mg/0.9 ml syringes with a ceiling value of $12,043.64. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), an indefinite delivery contract valued at up to $999,999,999.00 through December 2026 that provides pharmaceutical products and medical supplies to support military healthcare programs worldwide. Place of performance is Conshohocken, PA. The order...

The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, with a ceiling value of $58,983.31 for supply of Actemra 162 mg/0.9 mL syringes. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026, which enables delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs...

The Defense Logistics Agency awarded a $4,621.42 delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Actemra 162 mg/0.9 mL syringes. This is a firm fixed-price, non-set-aside contract with a completion date of January 29, 2026, and represents a child order under AmerisourceBergen's parent company, Cencora, Inc. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where the contractor maintains its corporate office. This delivery order falls under...

The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 9, 2026, with a ceiling value of $25,485.10 for supply of Actemra Actpen 162 mg/0.9 mL auto-injector units. Place of performance is Conshohocken, PA 19428. The order matures February 10, 2026. This is a firm fixed-price delivery order issued under no set-aside. The parent vehicle is the DLA Troop Support Medical indefinite delivery contract held by Cencora, Inc. (parent of the awardee), valued at...

The Defense Logistics Agency awarded a $649.75 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 162 milligram/0.9 milliliter syringes of Actemra. The single day contract has a period of performance from July 20, 2023 through July 21, 2023 and will be performed in Conshohocken, Pennsylvania. Actemra is a brand name biologic approved for the treatment of rheumatoid arthritis and other autoimmune conditions. This delivery order was issued under an...